INDUSTRY RESEARCH

Market intelligence across pharma, MedTech, and digital health.

3,460+ published studies covering therapeutics, diagnostics, devices, and healthcare services — sized bottom-up and top-down, validated by our dedicated Healthcare & Medical Devices research team, and delivered with country-level detail.

3,460+ Published studies
9 Sub-domains tracked
100+ Countries covered
Weekly New titles added
Our expertise in this vertical

The Healthcare & Medical Devices Research Team

This vertical is covered by a dedicated research group inside Fundamental Business Insights that tracks the global healthcare and medical technology industry full-time. Our analysts follow clinical adoption trends, regulatory developments, reimbursement policy, healthcare infrastructure investment, and evolving patient-care requirements as they happen — not just at the point a report is commissioned.

Every estimate in this vertical is built from primary conversations with healthcare stakeholders and cross-checked against company financial disclosures, regulatory publications, clinical literature, and government health databases, then reconciled through both bottom-up and top-down modeling before an internal quality review.

HC Reports in this section are prepared and reviewed by the Healthcare & Medical Devices research team.

Who we interview

Clinical KOLs, regulatory affairs heads, hospital procurement leads, and MedTech product & commercial teams.

Regulatory fluency

Analysts track FDA, EMA, and regional approval pathways so device and drug forecasts reflect real timelines.

Reimbursement modeling

Forecasts factor in payer policy and reimbursement shifts, not just clinical or technology adoption curves.

Coverage within this vertical

Sub-domains we track

Healthcare & Medical Devices reports on this site span the following sub-domains. Reports aren't filed under these as separate sub-categories yet — search or browse the full list below to find a specific market.

01

Pharmaceuticals

Small-molecule and branded/generic drug markets across therapeutic areas and dosage forms.

02

Biotechnology & Advanced Therapies

Cell and gene therapies, biologics, and next-generation biotech platforms.

03

Medical Devices

Diagnostic, surgical, monitoring, and implantable device categories across care settings.

04

Medical Diagnostics

In-vitro diagnostics, imaging, and point-of-care testing markets.

05

Analytical & Laboratory Technologies

Lab instrumentation, reagents, and analytical platforms used in research and clinical settings.

06

Healthcare IT & Digital Health

EHR platforms, telehealth, remote monitoring, and clinical software markets.

07

Clinical & Healthcare Services

Hospital operations, outpatient care, and healthcare service delivery models.

08

Veterinary Healthcare

Animal health diagnostics, pharmaceuticals, and veterinary device markets.

09

Life Science Research Tools

Instruments, reagents, and platforms supporting pharmaceutical and academic research.

These sub-domains describe the breadth of coverage in this vertical — the report list below isn't filterable by sub-domain. Use search or contact us if you're after a specific market.
Research intelligence

Secondary sources behind this vertical

Alongside primary interviews, every Healthcare & Medical Devices estimate is checked against these authoritative public and regulatory sources.

Secondary source Official website
World Health Organization (WHO) who.int ↗
U.S. Food & Drug Administration (FDA) fda.gov ↗
European Medicines Agency (EMA) ema.europa.eu ↗
Centers for Disease Control and Prevention (CDC) cdc.gov ↗
National Institutes of Health (NIH) nih.gov ↗
National Center for Biotechnology Information (NCBI) ncbi.nlm.nih.gov ↗
PubMed pubmed.ncbi.nlm.nih.gov ↗
ClinicalTrials.gov clinicaltrials.gov ↗
International Organization for Standardization (ISO) iso.org ↗
ASTM International astm.org ↗
Advanced Medical Technology Association (AdvaMed) advamed.org ↗
Medical Device Innovation Consortium (MDIC) mdic.org ↗
Biotechnology Innovation Organization (BIO) bio.org ↗
Int'l Federation of Pharmaceutical Manufacturers & Associations (IFPMA) ifpma.org ↗
U.S. Pharmacopeia (USP) usp.org ↗
European Directorate for the Quality of Medicines & HealthCare (EDQM) edqm.eu ↗
World Organisation for Animal Health (WOAH) woah.org ↗
American Hospital Association (AHA) aha.org ↗
OECD Health oecd.org/health ↗
World Bank Data data.worldbank.org ↗
Showing 41 – 50 of 4,607 Industry Research reports
Industry Research Oct 2026

RNA Based Therapeutics Market Size & Forecasts 2026-2035, By Segments (Technology, End-User, Application), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Moderna, BioNTech, Ionis Pharmaceuticals, Alnylam Pharmaceuticals, CureVac)

RNA Based Therapeutics Market size is forecast to climb from USD 15.32 billion in 2025 to USD 29.58 billion by 2035, expanding at a CAGR of over 6.8% during 2026-2035. Industry rev...

Industry Research Oct 2026

Aesthetics Injectables Market Size & Forecasts 2026-2035, By Segments (Product Type, Application, End-User), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (AbbVie, Ipsen, Revance Therapeutics, Ipsen, Revance Therapeutics)

Aesthetics Injectables Market size is predicted to expand from USD 10.7 billion in 2025 to USD 28.26 billion by 2035, with growth underpinned by a CAGR above 10.2% between 2026 and...

Industry Research Oct 2026

Cartilage Repair/Regeneration Market Size & Forecasts 2026-2035, By Segments (Treatment Modality, Application, End User, Application Site), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Zimmer Biomet, Stryker, Vericel Corporation, Histogenics Corporation, Medtronic)

Cartilage Repair/Regeneration Market size is anticipated to rise from USD 967.17 billion in 2025 to USD 1.99 trillion by 2035, reflecting a CAGR surpassing 7.5% over the forecast h...

Industry Research Oct 2026

Bio Decontamination Market Size & Forecasts 2026-2035, By Segments (Type, Product, Agent, End-User), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (STERIS, Ecolab, Cantel Medical, Sanuvox Technologies, TOMI Environmental Solutions)

Bio Decontamination Market size is likely to expand from USD 276.75 million in 2025 to USD 655.17 million by 2035, posting a CAGR above 9% across 2026-2035. The industry’s revenue...

Industry Research Oct 2026

Cell Based Assay Market Size & Forecasts 2026-2035, By Segments (End-User, Application, Product), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Thermo Fisher Scientific, Merck KGaA, PerkinElmer, Bio-Rad Laboratories, Danaher Corporation)

Cell Based Assay Market size is projected to expand significantly, moving from USD 22.09 billion in 2025 to USD 54.25 billion by 2035, with a CAGR of 9.4% during the 2026-2035 fore...

Industry Research Oct 2026

Healthcare Claims Management Solutions Market Size & Forecasts 2026-2035, By Segments (Component, Type, Delivery mode, End-user), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Optum, Change Healthcare, IBM Watson Health, Cognizant, McKesson)

Healthcare Claims Management Solutions Market size is projected to grow steadily from USD 15.3 billion in 2025 to USD 26.13 billion by 2035, demonstrating a CAGR exceeding 5.5% thr...

Industry Research Oct 2026

Non-Opioid Pain Patches Market Size & Forecasts 2026-2035, By Segments (Distribution Channel, Type), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Hisamitsu, 3M, Johnson & Johnson, Teva Pharmaceuticals, Hisun Pharmaceutical)

Non-Opioid Pain Patches Market size is expected to advance from USD 512.35 million in 2025 to USD 765.73 million by 2035, registering a CAGR of more than 4.1% across 2026-2035. By...

Industry Research Oct 2026

Sterile Packaging Market Size & Forecasts 2026-2035, By Segments (Material, Application, Type), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (WestRock, Amcor, Sealed Air, Berry Global, Sonoco)

Sterile Packaging Market size is forecast to climb from USD 67.66 billion in 2025 to USD 123.47 billion by 2035, expanding at a CAGR of over 6.2% during 2026-2035. Industry revenue...

Industry Research Oct 2026

Magnetic Resonance Imaging Systems Market Size & Forecasts 2026-2035, By Segments (Architecture, Field Strength), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Hitachi)

Magnetic Resonance Imaging Systems Market size is expected to advance from USD 6.71 billion in 2025 to USD 20.65 billion by 2035, registering a CAGR of more than 11.9% across 2026-...

Industry Research Oct 2026

Electronic Medical Record Market Size & Forecasts 2026-2035, By Segments (Solution, Application), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Epic Systems, Cerner, Allscripts, MEDITECH, McKesson)

Electronic Medical Record Market size is set to grow from USD 31.18 billion in 2025 to USD 50.79 billion by 2035, reflecting a CAGR greater than 5% through 2026-2035. Industry reve...

Need an Industry Research study we haven't published yet?

Our Healthcare team scopes custom studies using the same interview network and validation framework — typically delivered in 2–3 weeks.